Supplier
Epmed, PA
Epmed, PA was paid $46K by Medicaid between Apr 2021 and Aug 2022, across 21 billing codes. Its largest line is 99214, doctor's office visit, returning patient (more involved) — 97% of everything it billed.
33Billing provider infoEPMED, PA
LAS CRUCES, NM 88011
LAS CRUCES, NM 88011
33aNPI1700334075assigned 09/15/2016
33bProvider typeDurable Medical Equipment & Medical Supplies
28Total paid$46K
24GClaims3,259
24DCodes billed21
24AFirst – last monthApr 2021 – Aug 2022
Compared with peers
Next to other Durable Medical Equipment & Medical Supplies providers in New Mexico
Rank by total paid#35 of 69
Median peer was paid$46K
This provider vs. median1.0×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2021 | 1,620 | $43K | |
| 2022 | 1,639 | $3K |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 99214 | Doctor's office visit, returning patient (more involved)Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity | 97% | 1,039 | 1,013 | $45K |
| 80307 | Drug test(s), presumptive, any number of drug classes; immunoassay | 1.9% | 403 | 403 | $860.08 |
| 80050 | General health panel | <1% | 142 | 142 | $166.86 |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | <1% | 238 | 217 | $151.00 |
| G0482 | Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 15-21 drug class(es), including metabolite(s) if performed | <1% | 228 | 228 | $55.66 |
| 80305 | <1% | 148 | 148 | $36.48 | |
| 83735 | <1% | 190 | 190 | $30.46 | |
| 82550 | <1% | 191 | 190 | $28.62 | |
| 84100 | <1% | 189 | 189 | $20.98 | |
| 84550 | <1% | 187 | 187 | $19.21 | |
| 36415 | Collection of venous blood by venipuncture | <1% | 180 | 179 | $14.22 |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | <1% | 12 | 12 | $8.25 |
9 more codes
| J1885 | Injection, ketorolac tromethamine, per 15 mg | <1% | 12 | $7.89 |
| 77002 | 0% | 14 | $0.00 | |
| 83540 | 0% | 12 | $0.00 | |
| 83550 | 0% | 12 | $0.00 | |
| 80053 | Comprehensive metabolic panel | 0% | 12 | $0.00 |
| 82728 | 0% | 12 | $0.00 | |
| 82306 | Vitamin D; 25 hydroxy, includes fraction(s), if performed | 0% | 12 | $0.00 |
| 82607 | 0% | 12 | $0.00 | |
| G0480 | Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 1-7 drug class(es), including metabolite(s) if performed | 0% | 14 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialVAZQUEZ, EDUARDO (CEO)
| Provider | Location | Paid |
|---|---|---|
| Epmed, PA | El Paso, TX | $9.32M |
| Gateway Surgical Center, LLC | El Paso, TX | $143K |
| Epmed, PA | El Paso, TX | $141K |
Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.